FDA Clears Abionic’s IVD CAPSULE PSP for the early detection of Sepsis Epalinges, Switzerland, October 01, 2024 – Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to accelerate the
MindMaze Secures $105 Million Financing, Led by Concord Health Partners, to Fund Growth on Heels of Banner Year and Initiates American Hospital Association Partnership MindMaze (“the Company”), a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced it has secured a $105 million financing round to accelerate its global commercial growth plans, supercharge
Perseus Biomics selected as EIC 2021 startup champion European Innovation Council announces new wave of start-up champions Brussels, 14 October 2021The European Commission's European Innovation Council has selected 65 innovative start-ups and SMEs to receive €363 million of funding for breakthrough innovations. Each company will receive a combination of grant financing and equity
MindMaze Group Secures USD 125 Million Financing to Accelerate Commercialization and Expansion of its Digital Neurotherapeutics Platform LAUSANNE, Switzerland and PARIS and MONTPELLIER, France and LONDON and BALTIMORE, Oct. 7, 2021 /PRNewswire/ -- MindMaze, a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced the closing of a USD 125 million investment
Johns Hopkins, Mount Sinai turning to virtual rehab and video games to help patients recover from strokes The COVID-19 pandemic has brought experimentation in all different types of remote care, and that includes neuroscience. Physical therapists are exploring the use of tele-neurorehabilitation and gamification to help stroke victims recover. John Krakauer, M.D., professor of neurology,
A Look at Abionic’s abioSCOPE, a COVID-19 Severity Test Triage Tool Abionic’s abioSCOPE rapid diagnostic test generates results from a single drop of blood in less than five minutes. Image from Abionic. Swiss medtech company Abionic has developed a disease severity and triage tool for the identification of individuals with, or who are at
Swiss Firm Introduces Test to Spot Covid Patients Most at Risk A Swiss firm has introduced a blood test that can help hospitals more quickly pinpoint patients at risk of a severe form of Covid-19 as doctors seek ways to triage and prioritize medical treatment. Abionic SA said Thursday its method can be performed without medical training
Kindmore is proud being part of this new start-up.Perseus Biomics and Zeiss pact to develop optical way to map microbiome08-Jun-2020 By Will ChuMicrobiome analytics firm Perseus Biomics and optics giant Zeiss release details of a newly formed partnership that looks to create a new optical method for mapping the human microbiome.HTTPS://WWW.NUTRAINGREDIENTS.COM/ARTICLE/2020/06/05/PERSEUS-ZEISS-PACT-DEVELOPS-OPTICAL-WAY-TO-MAP-MICROBIOME Visit site
Mindmaze launched new website Go to the website
ABIONIC'S SEPSIS DIAGNOSTIC TEST COULD BE USEFUL IN COVID-19 Septic shock is one of the major complications of Covid-19. Vaud-based start-up Abionic, specialized in the miniaturization of diagnostic tests, has developed a test that can detect sepsis in five minutes. Abionic's solution detects sepsis in five minutes, which could be useful for severe cases